Back to Search Start Over

Association of nativity with survival among adults with hepatocellular carcinoma

Authors :
Kali Zhou
Ziwei Song
Nairi Rostomian
Jennifer L Dodge
Mariana C Stern
V Wendy Setiawan
Norah A Terrault
Myles G Cockburn
Lihua Liu
Source :
JNCI: Journal of the National Cancer Institute.
Publication Year :
2023
Publisher :
Oxford University Press (OUP), 2023.

Abstract

Introduction Immigrants comprise a considerable proportion of those diagnosed with hepatocellular carcinoma (HCC) in the United States. Nativity or birthplace affects incidence and risk factors for HCC, but little is known about its influence on survival after diagnosis. Methods We identified 51 533 adults with HCC with available birthplace in the California Cancer Registry between 1988 and 2017. HCC cases were categorized as foreign born or US born and stratified by mutually exclusive race and ethnicity groups. Primary outcome was all-cause mortality. Race and ethnicity–specific Cox regression propensity score-weighted models evaluated the relationship between nativity and death as well as region of birth among foreign-born patients. Results A total of 40% of all HCC cases were foreign born, and 92.2%, 45.2%, 9.1%, and 5.8% of Asian/Pacific Islander (API), Hispanic, White, and Black patients were foreign born, respectively. Five-year survival rates were higher in foreign-born patients compared with US-born patients: 12.9% vs 9.6% for White patients, 11.7% vs 9.8% for Hispanic patients, 12.8% vs 8.1% for Black patients, and 16.4% vs 12.4% for API patients. Nativity was associated with survival, with better survival in foreign-born patients: White patients: hazard ratio (HR) = 0.86 (95% confidence interval [CI] = 0.81 to 0.90), Hispanic patients: HR = 0.90 (95% CI = 0.86 to 0.93), Black patients: HR = 0.89 (95% CI = 0.76 to 1.05), and API patients: HR = 0.94 (95% CI = 0.88 to 1.00). Among foreign-born patients, lower mortality was observed in those from Central and South America compared with Mexico for Hispanic patients, East Asia compared with Southeast Asia for API patients, and East Europe and Greater Middle East compared with West/South/North Europe for White patients. Conclusion Foreign-born patients with HCC have better survival than US-born patients. Further investigation into the mechanisms of this survival disparity by nativity is needed.

Subjects

Subjects :
Cancer Research
Oncology

Details

ISSN :
14602105 and 00278874
Database :
OpenAIRE
Journal :
JNCI: Journal of the National Cancer Institute
Accession number :
edsair.doi...........8fa6a529b11fdbde5a35b9c00ae9a7be